DEA Proposes Significant Increase in Cannabis and Psychedelic Production for Research in 2023

The U.S. Drug Enforcement Administration (DEA) wants to more than double the amount of marijuana that can be legally produced for research in 2023, and it also seeks to significantly increase production quotas for psychedelics such as psilocyn, LSD and mescaline. In a notice scheduled to be published in the Federal Register next week, the DEA is proposing to grow about 6.7 million grams (or 14,770 pounds) of marijuana. Those growers approved by the DEA can now apply to become federal marijuana suppliers for research by the National Institute on Drug Abuse (NIDA). "These proposed 2023 quotas reflect the amounts DEA believes are necessary to meet the medical, scientific, research and industrial needs of the United States, including the increased demand for certain controlled substances used to treat COVID-19 patients; legal export requirements; and the establishment and maintenance of reserve stocks," DEA said.

Information source: mjbizdaily.com